AstraZeneca files lawsuit against the FDA for decision regarding quetiapine product labelling and exclusivity
AstraZeneca today filed a lawsuit against the US Food and Drug Administration (FDA) in...
Boehringer Ingelheim expands capabilities in biopharmaceutical process science
Ingelheim, Germany – Boehringer Ingelheim has expanded its biopharmaceutical development and manufacturing capabilities at...
Cytheris announces results of phase II study indicating that recombinant Interleukin-7 (CYT107) expands CD4...
Cytheris SA, a clinical stage biopharmaceutical company focused on development of new therapies for immune...
CiToxLAB increases inhalation test capabilities in North America and Europe
CiToxLAB, a leading CRO in the field of non-clinical research, announces today that it...
Almac expands in US with addition of Commercial Packaging facility in Almac Group
Having identified a business need in the US for a flexible and high quality...
ELC Group expands India presence with new operation at heart of world’s largest pharmaceutical...
ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, today announces that it has opened a...
Pharmaceutical regulatory affairs specialist ELC Group opens new office in Mumbai
ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, today announces that it has opened...
BioCity Scotland joins forces with Harrison Goddard Foote
BioCity Scotland, the newly-opened life sciences cluster in Newhouse, Lanarkshire, has signed a three-year agreement...
BHMS Investments Acquires Osmotics
BHMS Investments, LP, through affiliated funds, completed the acquisition of Osmotics Corporation , a...
European Commission approves Esmya® for the pre-operative treatment of uterine fibroids
Gedeon Richter Plc. announced today that the European Commission has granted marketing authorization to...
